These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18312349)

  • 1. Axillary tumour.
    Martins A; Serrão V; Fiadeiro T; Lopes MP; Campos F; Pereira H; Rodrigues JC
    Histopathology; 2008 Apr; 52(5):654-5. PubMed ID: 18312349
    [No Abstract]   [Full Text] [Related]  

  • 2. Glandular structures in an intraoperative axillary sentinel lymph node biopsy: a diagnostic dilemma.
    Nga ME; Putti TC
    Histopathology; 2006 Mar; 48(4):475-7. PubMed ID: 16487377
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer.
    Morcos B; Jaradat I; El-Ghanem M
    Eur J Surg Oncol; 2011 May; 37(5):418-21. PubMed ID: 21316187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Loss of hormonal receptors expression from primary breast carcinoma to axillary lymph node metastases].
    Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):540-4. PubMed ID: 14756058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive biology of pleomorphic lobular carcinoma of the breast.
    Moe RE; Anderson BO
    J Surg Oncol; 2005 May; 90(2):47-50. PubMed ID: 15844193
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of steroid hormone receptors with respect to tumor cellularity.
    Geppert M; Smyczek-Gargya B; Dietl J; Schneider H
    Zentralbl Pathol; 1993 Aug; 139(3):217-9. PubMed ID: 8218122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathologic diagnosis and histopathology record of breast cancer].
    Cserni G; Francz M; Járay B; Kálmán E; Kovács I; Kulka J; Orosz Z; Udvarhelyi N; Vass L
    Magy Onkol; 2010 Sep; 54(3):217-26. PubMed ID: 20870599
    [No Abstract]   [Full Text] [Related]  

  • 8. Metastatic lobular carcinoma in a ThinPrep Pap test: cytomorphology and differential diagnosis.
    Green KM; Turyan HV; Jones JB; Hoda RS
    Diagn Cytopathol; 2005 Jul; 33(1):58-9. PubMed ID: 15945085
    [No Abstract]   [Full Text] [Related]  

  • 9. Orbital tumour as a presenting symptom of breast carcinoma: value of detecting hormone receptors.
    Sekundo W; Vogel J
    Eye (Lond); 1997; 11 ( Pt 4)():560-3. PubMed ID: 9425424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations between hormone receptors, tumor size and axillary lymph node involvement in breast carcinoma. Initial results].
    Baldi F; Gallo A; Giannantoni C; Dell'Agli P; Caselli G
    Minerva Chir; 1988 Mar; 43(6):507-9. PubMed ID: 3399106
    [No Abstract]   [Full Text] [Related]  

  • 11. Biclonal breast carcinoma metastatic to a supraclavicular lymph node.
    Cimbaluk D; Usha L; Siziopikou KP
    Breast J; 2005; 11(6):488. PubMed ID: 16297106
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of ectopic lobular carcinoma in the axilla.
    Ma C; Yu Z; Wang S; Gao Y; Zuo W
    Am Surg; 2012 Jan; 78(1):E10-1. PubMed ID: 22273287
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
    Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
    Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microinvasive lobular carcinoma of the breast.
    Howat AJ; Armour A; Ellis IO
    Histopathology; 2000 Nov; 37(5):477-8. PubMed ID: 11119139
    [No Abstract]   [Full Text] [Related]  

  • 15. Fortuitous diagnosis in a uterine leiomyoma of metastatic lobular carcinoma of the breast.
    Liebmann RD; Jones KD; Hamid R; Lapsley M
    Histopathology; 1998 Jun; 32(6):577-8. PubMed ID: 9675605
    [No Abstract]   [Full Text] [Related]  

  • 16. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
    Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
    Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
    Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
    Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign Müllerian inclusions coexisting with breast metastatic carcinoma in an axillary lymph node.
    Piana S; Asioli S; Cavazza A
    Virchows Arch; 2005 Apr; 446(4):467-9. PubMed ID: 15785927
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of immunohistochemical markers in the diagnosis of carcinoma of the breast].
    Bussolati G
    Minerva Chir; 1988 Sep; 43(18 Suppl):5-7. PubMed ID: 3226595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.